Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial

Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial

Abstract Background Placebo medications, by definition, are composed of inactive ingredients that have no physiological effect on symptoms. Nonetheless, administration of placebo in randomized controlled trials (RCTs) and in clinical settings has been demonstrated to have significant impact on many...

Full description

Bibliographic Details
Main Authors: Sarah Ballou, Ted J. Kaptchuk, William Hirsch, Judy Nee, Johanna Iturrino, Kathryn T. Hall, John M. Kelley, Vivian Cheng, Irving Kirsch, Eric Jacobson, Lisa Conboy, Anthony Lembo, Roger B. Davis
Format: Article
Language:English
Published: BMC 2017-05-01
Series:Trials
Subjects:
Placebo effects
Open-label placebo
Irritable bowel syndrome
Research methods
Multi-disciplinary models
Peppermint oil
Online Access:http://link.springer.com/article/10.1186/s13063-017-1964-x

Internet

http://link.springer.com/article/10.1186/s13063-017-1964-x

Similar Items